Genmab AS (GMAB)
21.33
-0.34
(-1.57%)
USD |
NASDAQ |
Nov 14, 12:50
Genmab Market Cap: 13.55B for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 13.76B |
| November 12, 2024 | 14.27B |
| November 11, 2024 | 14.74B |
| November 08, 2024 | 14.66B |
| November 07, 2024 | 14.68B |
| November 06, 2024 | 14.18B |
| November 05, 2024 | 14.45B |
| November 04, 2024 | 14.47B |
| November 01, 2024 | 14.33B |
| October 31, 2024 | 14.18B |
| October 30, 2024 | 14.34B |
| October 29, 2024 | 14.68B |
| October 28, 2024 | 14.70B |
| October 25, 2024 | 14.68B |
| October 24, 2024 | 14.49B |
| October 23, 2024 | 14.44B |
| October 22, 2024 | 14.46B |
| October 21, 2024 | 14.47B |
| October 18, 2024 | 14.60B |
| October 17, 2024 | 14.58B |
| October 16, 2024 | 14.35B |
| October 15, 2024 | 14.72B |
| October 14, 2024 | 15.03B |
| October 11, 2024 | 14.94B |
| October 10, 2024 | 15.06B |
| Date | Value |
|---|---|
| October 09, 2024 | 15.02B |
| October 08, 2024 | 14.98B |
| October 07, 2024 | 14.88B |
| October 04, 2024 | 14.92B |
| October 03, 2024 | 14.86B |
| October 02, 2024 | 15.05B |
| October 01, 2024 | 15.34B |
| September 30, 2024 | 15.48B |
| September 27, 2024 | 15.45B |
| September 26, 2024 | 15.32B |
| September 25, 2024 | 15.13B |
| September 24, 2024 | 15.25B |
| September 23, 2024 | 15.33B |
| September 20, 2024 | 16.21B |
| September 19, 2024 | 16.82B |
| September 18, 2024 | 16.64B |
| September 17, 2024 | 16.78B |
| September 16, 2024 | 16.88B |
| September 13, 2024 | 17.08B |
| September 12, 2024 | 16.82B |
| September 11, 2024 | 17.10B |
| September 10, 2024 | 17.46B |
| September 09, 2024 | 17.44B |
| September 06, 2024 | 17.47B |
| September 05, 2024 | 17.58B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
11.15B
Minimum
Mar 16 2020
31.85B
Maximum
Sep 03 2021
22.31B
Average
23.07B
Median
Sep 28 2023
Market Cap Benchmarks
| Novo Nordisk AS | 472.58B |
| Ascendis Pharma AS | 7.580B |
| Galecto Inc | 8.969M |
| Evaxion Biotech AS | 10.15M |
| IO Biotech Inc | 59.29M |
Market Cap Related Metrics
| PE Ratio | 20.27 |
| PS Ratio | 4.813 |
| PEG Ratio | 1.356 |
| Price to Book Value | 2.833 |
| Price to Free Cash Flow | 14.49 |
| Price | 21.33 |
| Earnings Yield | 4.93% |
| PEGY Ratio | 1.356 |
| Operating PE Ratio | 14.72 |
| Normalized PE Ratio | 17.93 |